… USA. ProQR is focused on the development of life-changing RNA therapies to meet the unmet needs of individuals and … of the communities we serve. Our proprietary Axiomer® RNAediting technology platform enables the editing of specific …
… USA. ProQR is focused on the development of life changing RNA therapies to meet the unmet need of individuals and … of the communities we serve. Our proprietary Axiomer® RNAediting technology platform enables the editing of specific …
ProQR will present new preclinical data for Axiomer, including the first preclinical data for its AX-0810 pipeline program for cholestatic diseases targeting NTCP at the ASGCT Annual Meeting, May 7-11, 2024, in Baltimore, Maryland.
… USA. ProQR is focused on the development of life-changing RNA therapies to meet the unmet need of individuals and … of the communities we serve. Our proprietary Axiomer® RNAediting technology platform enables the editing of specific …